Skip to main content

Articles

Page 14 of 16

  1. In European countries, low-molecular-weight heparin is generally initiated preoperatively for thromboprophylaxis in hip or knee replacement surgery. The objective of this review is to compare pre- and postoper...

    Authors: Carsten Perka
    Citation: Thrombosis Journal 2011 9:17
  2. To assess the incidence of venous thromboembolism (VTE) and bleeding events with or without thromboprophylaxis and the associated costs in a cohort of medically ill patients in both in-hospital and outpatient ...

    Authors: Li Wang, Nishan Sengupta and Onur Baser
    Citation: Thrombosis Journal 2011 9:15
  3. Patients who receive highly variable doses of warfarin may be at risk for poor anticoagulation control and adverse events. However, we lack a system to identify patients with the highest dose variability. Our ...

    Authors: Lyndonna Marrast, Mary Evans, Al Ozonoff, Lori E Henault and Adam J Rose
    Citation: Thrombosis Journal 2011 9:14
  4. The ergotamine tartrate associated with certain categories of drugs can lead to critical ischemia of the extremities. Discontinuation of taking ergotamine is usually sufficient for the total regression of isch...

    Authors: Edoardo Cervi, Stefano Bonardelli, Giuseppe Battaglia, Federico Gheza, Roberto Maffeis, Franco Nodari, Roberto Maroldi and Stefano M Giulini
    Citation: Thrombosis Journal 2011 9:13
  5. Patients with vasospastic (VA) or non vasospastic angina (NVA) without significant coronary stenosis have a reduced risk of infarction but is unclear whether or not this may be attributable to a lack of prothr...

    Authors: Jaume Figueras, Jasone Monasterio, Enric Domingo, Beatriz Meneses, Elsa Nieto, Josefa Cortadellas and David Garcia-Dorado
    Citation: Thrombosis Journal 2011 9:10
  6. We report a case of near fatal aortic thrombosis in a trauma patient homozygous for mutation of Factor V Leiden. He responded well to vascular surgery and intensive care unit management and was discharged succ...

    Authors: Iraklis Tsangaris, Georgios Tsaknis, Argirios Tsantes, Petros Kopterides and Apostolos Armaganidis
    Citation: Thrombosis Journal 2011 9:8
  7. Venous thromboembolism (VTE) is a major health and financial burden. VTE impacts health outcomes in surgical and non-surgical patients. VTE prophylaxis is underutilized, particularly amongst high risk medical ...

    Authors: Harry Gibbs, John Fletcher, Peter Blombery, Renea Collins and David Wheatley
    Citation: Thrombosis Journal 2011 9:7
  8. Mature carotid plaques are complex structures, and their histological classification is challenging. The carotid plaques of asymptomatic and symptomatic patients could exhibit identical histological components.

    Authors: Liz Andréa V Baroncini, Lia S Nakao, Simone G Ramos, Antonio Pazin Filho, Luiz Otávio Murta Jr, Max Ingberman, Cristiane Tefé-Silva and Dalton B Précoma
    Citation: Thrombosis Journal 2011 9:6
  9. Different platelet function tests can be used to evaluate the degree of achieved platelet inhibition in patients treated with clopidogrel. The presence of CYP 2C19*2 polymorphism can reduce the formation of th...

    Authors: Alf-Aage R Pettersen, Harald Arnesen, Trine B Opstad and Ingebjorg Seljeflot
    Citation: Thrombosis Journal 2011 9:4
  10. Patients undergoing elective total hip replacement (THR) surgery are at an increased risk for venous thromboembolic events (VTEs). Dalteparin and enoxaparin are recommended as thromboprophylaxis for at least 1...

    Authors: George Dranitsaris, Valentina Jelincic and Yoonhee Choe
    Citation: Thrombosis Journal 2011 9:3
  11. Recent literature reports an increased incidence of venous thrombosis following thalidomide use in the treatment of diseases with disease-related thrombotic risks such as malignancy, as well as concomitant use...

    Authors: Riyaaz Ahamed, Wijesiriwardena Bandula and Ratnayake Chamara
    Citation: Thrombosis Journal 2011 9:2
  12. Cirrhotic patients are characterized by a decreased synthesis of coagulation and anticoagulation factors. The coagulopathy of cirrhotic patients is considered to be auto-anticoagulation. Our aim was to determi...

    Authors: Abdulaziz Aldawood, Yaseen Arabi, Abdulrahman Aljumah, Alawi Alsaeedi, Asgar Rishu, Hasan Aldorzi, Saad Alqahtani, Mohammad Alsultan and Afaf Felemban
    Citation: Thrombosis Journal 2011 9:1
  13. Patients with gynecologic cancer have a high risk of venous thromboembolism (VTE) like patients with other cancers. However, there is little information on risk factors for VTE during gynecologic surgery and n...

    Authors: Nao Suzuki, Norihito Yoshioka, Tatsuru Ohara, Noriyuki Yokomichi, Takafumi Nako, Namiko Yahagi, Suguru Igarashi, Yoichi Kobayashi, Misako Yoshimatsu, Kenji Takizawa, Yasuo Nakajima, Kazushige Kiguchi and Bunpei Ishizuka
    Citation: Thrombosis Journal 2010 8:17
  14. Periodontitis is associated with cardiovascular diseases (CVD). In our previous studies a prothrombotic state has been observed in periodontitis, which contributes to the risk of CVD. The aim of this study was...

    Authors: Sergio Bizzarro, Elena A Nicu, Ubele van der Velden, Marja L Laine and Bruno G Loos
    Citation: Thrombosis Journal 2010 8:16
  15. Left ventricular thrombus(LVT] formation is a frequent complication in patients with acute anterior myocardial infarction(MI). LVT is associated with increased risk of embolism and higher mortality rates after...

    Authors: Ertuğrul Okuyan, Barış Okcun, Mustafa H Dinçkal and Haşim Mutlu
    Citation: Thrombosis Journal 2010 8:15
  16. The chemokine receptors CCR2 and CX3CR1 are important in the development of coronary artery disease. The purpose of this study is to analyze the effect of a novel CCR2 inhibitor in conjunction with CX3CR1 dele...

    Authors: Maya R Jerath, Peng Liu, Mary Struthers, Julie A DeMartino, Roche Peng, Laurence B Peterson, Anne-Marie Cumiskey, Lihu Yang, Mauricio Rojas, Dhavalkumar D Patel and Alan M Fong
    Citation: Thrombosis Journal 2010 8:14
  17. Beta-lactam antibiotics, e.g. penicillin, may inhibit platelet function and lead to reduced response in light transmission aggregometry and adhesion. However, influence on platelet function tests more commonly...

    Authors: Christian Schulz, Olga von Beckerath, Rainer Okrojek, Nicolas von Beckerath and Steffen Massberg
    Citation: Thrombosis Journal 2010 8:13
  18. Normal pregnancy corresponds to a procoagulant state. Acute myocardial infarction during pregnancy is rare, yet considering the low non-pregnant risk score of childbearing women it is still surprisingly freque...

    Authors: Spyridon Arampatzis, Ioannis Stefanidis, Vassilios Liakopoulos, Luigi Raio, Daniel Surbek and Markus G Mohaupt
    Citation: Thrombosis Journal 2010 8:12
  19. Information on hemostasis and platelet function in brown bear (Ursus arctos) is of importance for understanding the physiological, protective changes during hibernation.

    Authors: Ole Fröbert, Kjeld Christensen, Åsa Fahlman, Sven Brunberg, Johan Josefsson, Eva Särndahl, Jon E Swenson and Jon M Arnemo
    Citation: Thrombosis Journal 2010 8:11
  20. Protein C (PC) and protein S (PS) determination is part of the thrombophilia investigation in patients with idiopathic venous thromboembolism (VTE). Based on scarce evidence it is a common notion that PC and P...

    Authors: Leonard Minuk, Alejandro Lazo-Langner, Judy Kovacs, Melinda Robbins, Bev Morrow and Michael Kovacs
    Citation: Thrombosis Journal 2010 8:10
  21. Poor platelet inhibition by aspirin or clopidogrel has been associated with adverse outcomes in patients with cardiovascular diseases. A reliable and facile assay to measure platelet inhibition after treatment...

    Authors: Sandra M Penz, Isabell Bernlochner, Orsolya Tóth, Reinhard Lorenz, Andreas Calatzis and Wolfgang Siess
    Citation: Thrombosis Journal 2010 8:9
  22. High concentrations of recombinant activated factor VII (rFVIIa) can stop bleeding in hemophilic patients. However the rFVIIa dose needed for stopping haemhorrage in off-label indications is unknown. Since thr...

    Authors: Raul Altman, Alejandra Scazziota, Maria de Lourdes Herrera and Claudio D Gonzalez
    Citation: Thrombosis Journal 2010 8:8
  23. Tissue factor (TF) and its inhibitor tissue factor pathway inhibitor (TFPI) are the main regulators of the initiation of the coagulation process, important in atherothrombosis. In this study we have investigat...

    Authors: Trine B Opstad, Alf Åge Pettersen, Thomas Weiss, Harald Arnesen and Ingebjørg Seljeflot
    Citation: Thrombosis Journal 2010 8:7
  24. The pathophysiological pathways resulting in Late Stent Thrombosis (LST) remain uncertain. Findings from animal studies indicate a role of the intrinsic coagulation pathway in arterial thrombus formation, whil...

    Authors: Volker Pönitz, José W Govers-Riemslag, Hugo ten Cate, Rene van Oerle, Trygve Brügger-Andersen, Heidi Grundt, Patrycja Næsgaard, David Pritchard, Alf I Larsen and Dennis W Nilsen
    Citation: Thrombosis Journal 2010 8:6
  25. Despite the high frequency with which adverse drug events (ADEs) occur in outpatient settings, detailed information regarding these events remains limited. Anticoagulant drugs are associated with increased saf...

    Authors: Andrea L Long, Lisa Bendz, Monica M Horvath, Heidi Cozart, Julie Eckstrand, Julie Whitehurst and Jeffrey Ferranti
    Citation: Thrombosis Journal 2010 8:5
  26. Postoperative asymptomatic deep venous thromboses (ADVT) can give rise to posttthrombotic syndrome (PTS), but there are still many unresolved issues in this context. For example, there is a lack of knowledge r...

    Authors: Stefan Rosfors, Lena M Persson, Gerd Lärfars and Lasse J Lapidus
    Citation: Thrombosis Journal 2010 8:4
  27. Experimental models of pulmonary embolism (PE) that produce pulmonary hypertension (PH) employ many different methods of inducing acute pulmonary occlusion. Many of these models induce PE with intravenous inje...

    Authors: Michael S Runyon, Michael A Gellar, Nina Sanapareddy, Jeffrey A Kline and John A Watts
    Citation: Thrombosis Journal 2010 8:3
  28. Interaction of fibrinogen with specific leukocyte integrins of monocytes may link coagulation and inflammation, however, the precise mechanism of fibrinogen leading to the pro-inflammatory and pro-coagulatory ...

    Authors: Nicole C Kaneider, Birgit Mosheimer, Andrea Günther, Clemens Feistritzer and Christian J Wiedermann
    Citation: Thrombosis Journal 2010 8:2
  29. The expression of pregnancy-associated plasma protein A (PAPP-A) was identified by immunohistochemistry (IHC) in culprit atherothrombotic plaque specimens harvested from patients admitted with ST-segment eleva...

    Authors: Trygve Brügger-Andersen, Leif Bostad, Dagny Ann Sandnes, AlfInge Larsen, Vernon VS Bonarjee, Ståle Barvik, Tor Melberg and Dennis WT Nilsen
    Citation: Thrombosis Journal 2010 8:1
  30. Hemostasis is a defense mechanism to stop bleeding. Activated by vessel wall injury, it consists of intertwined activation of platelets and the coagulation cascade, tightly controlled by natural anticoagulants...

    Authors: Peter Verhamme and Marc F Hoylaerts
    Citation: Thrombosis Journal 2009 7:15
  31. Low molecular weight heparin (LMWH) is in vast usage for treatment of thromboembolic diseases such as deep venous thrombosis and acute coronary syndromes. There are certain clinical situations where a quick po...

    Authors: Ramin Artang, Niels J Frandsen and Jørn Dalsgaard Nielsen
    Citation: Thrombosis Journal 2009 7:14
  32. Myocardial infarction is the combined result of environmental factors and personal predispositions. Prothrombotic factors might play an important role in this phenomenon. Annexin V (ANV) is a calcium-dependent...

    Authors: Mohammad Shojaie, Abdoreza Sotoodah, Shohre Roozmeh, Ensieh Kholoosi and Samira Dana
    Citation: Thrombosis Journal 2009 7:13
  33. Recurrent cardiovascular events following acute myocardial infarction (AMI) are common. The purpose of this study was to evaluate the impact of platelet aggregation, PFA-100 closure times and peak C-reactive p...

    Authors: Angelo Modica, Fredrik Karlsson and Thomas Mooe
    Citation: Thrombosis Journal 2009 7:12
  34. Tissue factor (TF) contributes to thrombosis following plaque disruption in acute coronary syndromes (ACS). Aim of the study was to investigate the impact of plasma TF activity on prognosis in patients with ACS.

    Authors: Birgit A Steppich, Siegmund Lorenz Braun, Andreas Stein, Gabriele Demetz, Philip Groha, Albert Schömig, Nicolas von Beckerath, Adnan Kastrati and Ilka Ott
    Citation: Thrombosis Journal 2009 7:11
  35. Endothelial cell dysfunction, by promoting fibrin deposition, has been implicated in the development of multiple organ failure. Altered fibrinolysis during inflammation may participate in microvascular alterat...

    Authors: Karim Zouaoui Boudjeltia, Sandra Ollieuz, Michael Piagnerelli, Patrick Biston, Philippe Cauchie, Jean-Louis Vincent, Dany Brohee and Michel Vanhaeverbeek
    Citation: Thrombosis Journal 2009 7:10
  36. The Azorean population presents the highest standardized mortality rate for cardiovascular diseases (CVD) when compared to mainland Portugal and other populations. Since thrombosis is a common cause of CVD, we...

    Authors: Claudia C Branco, Tânia Pereirinha, Rita Cabral, Paula R Pacheco and Luisa Mota-Vieira
    Citation: Thrombosis Journal 2009 7:9
  37. The aim of this case report is to describe control of Schamberg's disease using aminaphtone. We report on the case of a 28-year-old patient who presented with multiple purpuric lesions of the lower extremities...

    Authors: José Maria Pereira de Godoy and Fernando Batigália
    Citation: Thrombosis Journal 2009 7:8
  38. Every year, millions of people undergo percutaneous coronary intervention (PCI) with intracoronary stent implantation. A patient from the PRAGUE-8 trial (Optimal pre-PCI clopidogrel loading: 600 mg before ever...

    Authors: Zuzana Motovska, Petr Widimsky, Iuri Marinov, Robert Petr, Jaroslava Hajkova and Jan Kvasnicka
    Citation: Thrombosis Journal 2009 7:6
  39. A 27 year-old man who presented to the hospital with progressive lower extremity weakness, developed an acute ST elevation myocardial infarction on his second hospital day. Primary angioplasty to the left ante...

    Authors: Ayyash Melhem, Ankit Desai and Marion A Hofmann
    Citation: Thrombosis Journal 2009 7:5
  40. Dual anti-platelet therapy with aspirin and a thienopyridine (DAT) is used to prevent stent thrombosis after percutaneous coronary intervention (PCI). Low response to clopidogrel therapy (LR) occurs, but labor...

    Authors: Cosmo Godino, Loredana Mendolicchio, Filippo Figini, Azeem Latib, Andrew SP Sharp, John Cosgrave, Giliola Calori, Michela Cera, Alaide Chieffo, Alfredo Castelli, Attilio Maseri, Zaverio M Ruggeri and Antonio Colombo
    Citation: Thrombosis Journal 2009 7:4
  41. Mild hypothermia is currently standard of care for cardiac arrest patients in many hospitals and a common belief is that hypothermia attenuates platelet aggregation. We wanted to examine the effects of clopido...

    Authors: Carl Högberg, David Erlinge and Oscar Ö Braun
    Citation: Thrombosis Journal 2009 7:2
  42. A 68-year-old woman presented with acute chest pain and a greatly increased platelet count. Cardiac catheterization revealed subtotal occlusion and a thrombus-like filling defect in the right coronary artery. ...

    Authors: Emin Alioglu, Nurullah Tuzun, Fahri Sahin, Buket Kosova, Serkan Saygi, Istemihan Tengiz, Ugur Turk, Nazan Ozsan and Ertugrul Ercan
    Citation: Thrombosis Journal 2009 7:1
  43. Disturbed cellular cholesterol homeostasis may lead to accumulation of cholesterol in human atheroma plaques. Cellular cholesterol homeostasis is controlled by the sterol regulatory element-binding transcripti...

    Authors: Yue-Mei Fan, Pekka J Karhunen, Mari Levula, Erkki Ilveskoski, Jussi Mikkelsson, Olli A Kajander, Otso Järvinen, Niku Oksala, Janita Thusberg, Mauno Vihinen, Juha-Pekka Salenius, Leena Kytömäki, Juhani T Soini, Reijo Laaksonen and Terho Lehtimäki
    Citation: Thrombosis Journal 2008 6:17

Official journal of

  • Thrombosis Journal is the official journal of the Asian-Pacific Society on Thrombosis and Hemostasis.

Annual Journal Metrics

  • 2022 Citation Impact
    3.1 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.011 - SNIP (Source Normalized Impact per Paper)
    0.699 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    107 days submission to accept (Median)

    2023 Usage 
    708,004 downloads
    943 Altmetric mentions